User profiles for Gaojun Teng
 | Teng GaojunProfessor of Radiology, Southeast University Verified email at seu.edu.cn Cited by 16841 |
Regional homogeneity in depression and its relationship with separate depressive symptom clusters: a resting-state fMRI study
Z Yao, L Wang, Q Lu, H Liu, G Teng - Journal of affective disorders, 2009 - Elsevier
BACKGROUND: Using a newly reported regional homogeneity (ReHo) approach, we were
to explore the features of brain activity of patients with major depressive disorder (MDD) in …
to explore the features of brain activity of patients with major depressive disorder (MDD) in …
Impairments in cognition and resting-state connectivity of the hippocampus in elderly subjects with type 2 diabetes
H Zhou, W Lu, Y Shi, F Bai, J Chang, Y Yuan, G Teng… - Neuroscience …, 2010 - Elsevier
Type 2 diabetes mellitus (T2DM) is associated with an increased risk of Alzheimer's disease,
which involves hippocampus-mediated cognitive impairment. The present study …
which involves hippocampus-mediated cognitive impairment. The present study …
[HTML][HTML] Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)
…, Z Zhu, S Qin, F Shen, X Cai, G Teng… - … surgery and nutrition, 2022 - ncbi.nlm.nih.gov
Recent advances in systemic and locoregional treatments for patients with unresectable or
advanced hepatocellular carcinoma (HCC) have resulted in improved response rates. This …
advanced hepatocellular carcinoma (HCC) have resulted in improved response rates. This …
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 …
…, T Yin, J Cui, M Huang, B Xing, Y Mao, G Teng… - The Lancet …, 2021 - thelancet.com
Background China has a high burden of hepatocellular carcinoma, and hepatitis B virus (HBV)
infection is the main causative factor. Patients with hepatocellular carcinoma have a poor …
infection is the main causative factor. Patients with hepatocellular carcinoma have a poor …
[HTML][HTML] Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition)
…, J Zhu, K Zhu, R Liu, Y Shi, Y Xiao, Z Dai, G Teng… - Liver cancer, 2020 - karger.com
Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is
the fourth most common malignancy and the second leading cause of tumor-related death, …
the fourth most common malignancy and the second leading cause of tumor-related death, …
Re‐evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert …
…, RT Poon, CK Tan, T Tanwandee, G Teng… - Liver …, 2014 - Wiley Online Library
Patients with unresectable hepatocellular carcinoma ( HCC ) usually receive transarterial
chemoembolization ( TACE ) or systemic therapies with intermediate and advanced‐stage …
chemoembolization ( TACE ) or systemic therapies with intermediate and advanced‐stage …
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
…, RT Poon, CK Tan, T Tanwandee, G Teng… - Liver …, 2013 - Wiley Online Library
Hepatocellular carcinoma ( HCC ) presents with a high burden of disease in East Asian
countries. Intermediate‐stage HCC as defined by the Barcelona Clinic Liver Cancer ( BCLC ) …
countries. Intermediate‐stage HCC as defined by the Barcelona Clinic Liver Cancer ( BCLC ) …
[HTML][HTML] Fluorescence modified chitosan-coated magnetic nanoparticles for high-efficient cellular imaging
Y Ge, Y Zhang, S He, F Nie, G Teng, N Gu - Nanoscale research letters, 2009 - Springer
Labeling of cells with nanoparticles for living detection is of interest to various biomedical
applications. In this study, novel fluorescent/magnetic nanoparticles were prepared and used …
applications. In this study, novel fluorescent/magnetic nanoparticles were prepared and used …
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open …
…, B Wang, Y Bai, Y He, H Zhao, D Zhou, C Dai, G Teng… - The Lancet, 2023 - thelancet.com
Background No adjuvant treatment has been established for patients who remain at high
risk for hepatocellular carcinoma recurrence after curative-intent resection or ablation. We …
risk for hepatocellular carcinoma recurrence after curative-intent resection or ablation. We …
A Hydrogen Peroxide‐Responsive O2 Nanogenerator for Ultrasound and Magnetic‐Resonance Dual Modality Imaging
…, X Cai, Y Huang, F Wang, S Wen, G Teng… - Advanced …, 2012 - Wiley Online Library
The environmental stress from the exposure to toxin and drugs may induce the production
of reactive oxygen species (ROS).[1] ROS are high-energy oxygen-bearing molecules …
of reactive oxygen species (ROS).[1] ROS are high-energy oxygen-bearing molecules …